Trial Profile
Study of strategy for secondary failure of infliximab maintenance therapy to measure anti-infliximab antibody levels in patients with inflammatory bowel disease.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2017
Price :
$35
*
At a glance
- Drugs Infliximab (Primary) ; Adalimumab
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Therapeutic Use
- Acronyms IFXATIIBD
- 21 Feb 2017 New trial record